Salary
💰 $210,000 - $240,000 per year
About the role
- Mineralys Therapeutics is a clinical-stage biotechnology company developing lorundrostat, an aldosterone synthase inhibitor for cardiorenal conditions
- Lead creation of a data-driven value proposition tailored to payer and policy stakeholders
- Collaborate with Medical Affairs, HEOR, and Clinical teams to align messaging with product profile and unmet need
- Develop payer-facing materials including AMCP dossiers, PIE, and value decks
- Identify evidence gaps and prioritize evidence needs to support access and reimbursement goals
- Partner with HEOR and RWE teams to guide development of economic models, burden-of-illness studies, and comparative effectiveness research
- Develop pricing scenarios and recommendations and design innovative contracting approaches including value-based agreements
- Serve as the internal market access lead for the cardiovascular launch team and provide strategic input to Commercial, Medical, Regulatory, and Finance teams
- Monitor reimbursement policies, HTA trends, and payer expectations and translate external insights into actionable internal strategies
Requirements
- 10+ years of experience in market access, pricing, HEOR, or strategy roles within the pharmaceutical industry
- Demonstrated success in developing access strategies for specialty or cardiovascular products
- Strong understanding of U.S. payer systems, reimbursement pathways, and value demonstration frameworks
- Exceptional analytical, strategic thinking, and communication skills
- Advanced degree preferred (MBA, MPH, PharmD, or equivalent)
- Demonstrated ability to operate effectively in ambiguous, fast-changing environments, with a proactive and solution-oriented mindset